Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial
Read more at MarketWatch
Topics
-
Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms
Business - MarketWatch - October 24 -
Hoping for a weight-loss pill? It could get closer to reality next week.
Business - MarketWatch - 2 days ago -
Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
Business - CNBC - October 15 -
Eli Lilly to trial use of weight loss drugs to combat unemployment in U.K.
Top stories - NBC News - October 16 -
Weight-loss drugs show promise in tackling opioid and alcohol abuse
World - Financial Times - October 17 -
LOOK: Former NFL OT Jake Long shows off dramatic weight loss at Michigan Sports Hall of Fame induction
Sports - CBS Sports - October 18
More from MarketWatch
-
Palantir’s stock surges as AI drives a further acceleration in growth
Business - MarketWatch - 2 hours ago -
Marqeta’s stock may shed a third of its value as these factors spur weak outlook
Business - MarketWatch - 2 hours ago -
Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating’
Business - MarketWatch - 2 hours ago -
Dollar Tree’s CEO steps down. An analyst says the move comes at a ‘difficult time.’
Business - MarketWatch - 2 hours ago -
Super Micro needs a new CEO before its AI advantage erodes
Business - MarketWatch - 3 hours ago
Latest in Business
-
Chinese equities outperform ahead of US election
Business - Financial Times - 1 hour ago -
Trump's tariffs could trigger 'dramatic' price spikes on clothes, furniture, warns retail group
Business - CNBC - 2 hours ago -
Palantir’s stock surges as AI drives a further acceleration in growth
Business - MarketWatch - 2 hours ago -
Marqeta’s stock may shed a third of its value as these factors spur weak outlook
Business - MarketWatch - 2 hours ago -
Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating’
Business - MarketWatch - 2 hours ago